Review



cancer type source morphology atcc number designation  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    ATCC cancer type source morphology atcc number designation
    Cell lines used.
    Cancer Type Source Morphology Atcc Number Designation, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissue+array+blocks+bl2081/NCI-BL2087/pmc04586259-73-36-40
    Average 90 stars, based on 3 article reviews
    cancer type source morphology atcc number designation - by Bioz Stars, 2026-11
    90/100 stars

    Images

    1) Product Images from "Base Excision Repair Activities Differ in Human Lung Cancer Cells and Corresponding Normal Controls"

    Article Title: Base Excision Repair Activities Differ in Human Lung Cancer Cells and Corresponding Normal Controls

    Journal: Anticancer research

    doi:

    Cell lines used.
    Figure Legend Snippet: Cell lines used.

    Techniques Used:

    Related Articles

    Isolation:

    Article Title: Base Excision Repair Activities Differ in Human Lung Cancer Cells and Corresponding Normal Controls
    Article Snippet: .. The cells were harvested at 80% confluence with trypsin, washed with PBS, and immediately processed for mitochondria and nuclei isolation. table ft1 table-wrap mode="anchored" t5 caption a7 Tumor cell lines Normal cell lines ATCC number (Designation) Cancer type Source Morphology ATCC number (Designation) Source Morphology NCI-H2087 ( CRL-5922 ) Adenocarcinoma; non-small cell lung cancer Lymphonode Epithelial NCI-BL2087 ( CRL-5965 ) Peripheral blood Lymphoblast NCI-H2107 ( CRL-5983 ) Carcinoma, small cell lung cancer Bone marrow Epithelial NCI-BL2107 ( CRL-5966 ) Peripheral blood Lymphoblast NCI-H2052 ( CRL-5915 ) Mesothelioma Pleural effusion – NCI-BL2052 ( CRL-5963 ) Peripheral blood Lymphoblast Open in a separate window Cell lines used. .. CRL-5915 (NCI-H2052) cells were cultured in RPMI-1640 medium supplemented with 10% FBS.

    other:

    Article Title: Comments on Sneath, P. H. A. and Skerman, V. B. D. (1966) "A new list of type and reference strains of bacteria" Int. J. Syst. Bact., 16(1):1-133
    Article Snippet: ATCC 4873, NCIB 5965, NCDO 567, HMS E. 6.1.



    Similar Products

    tissue array blocks bl2081  (Biomax Inc)
    90
    Biomax Inc tissue array blocks bl2081
    A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays <t>BL2081</t> and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.
    Tissue Array Blocks Bl2081, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissue+array+blocks+bl2081/tissue+array+blocks+bl+806/pmc05628127-142-2-9
    Average 90 stars, based on 1 article reviews
    tissue array blocks bl2081 - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.

    Journal: Molecular cancer therapeutics

    Article Title: Epidermal Growth Factor Receptor (EGFR) Targeted Photoimmunotherapy (PIT) for the Treatment of EGFR expressing Bladder Cancer

    doi: 10.1158/1535-7163.MCT-16-0924

    Figure Lengend Snippet: A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.

    Article Snippet: Commercially available tissue array blocks BL2081 and BL 806 (Biomax, Rockville, MD) were similarly stained with anti-EGFR antibody to detect the expression of EGFR in bladder tumors of various stages, grades, and histologies as well as adjacent normal bladder tissues.

    Techniques: Staining, Expressing